IL6 and pulmonary emphysema: While this study was unique in that it featured two large well-characterized cohorts, confirmed strong associations of IL-6 and eotaxin, identified new pQTL SNPs, and identified potentially new biomarkers of COPD and emphysema progression, there were some important limitations.